| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 685285 | Null | 0.0352028253287042 | 0.042667544 |
| NSC 685964 | Null | 0.0352028253287042 | 0.1470825 |
| NSC 688228 | Null | 0.0352028253287042 | 0.15065371 |
| NSC 701022 | Null | 0.0352028253287042 | 0.31351474 |
| NSC 703784 | L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride | 0.0352028253287042 | -0.23053556 |
| NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.0352028253287042 | 0.31290078 |
| NSC 715407 | Null | 0.0352028253287042 | 0.096415248 |
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.0352028253287042 | 0.1999925 |
| NSC 720495 | Null | 0.0352028253287042 | 0.20901317 |
| NSC 726578 | Null | 0.0352028253287042 | 0.29537606 |